全文获取类型
收费全文 | 1271篇 |
免费 | 58篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 68篇 |
妇产科学 | 15篇 |
基础医学 | 122篇 |
口腔科学 | 19篇 |
临床医学 | 78篇 |
内科学 | 241篇 |
皮肤病学 | 59篇 |
神经病学 | 15篇 |
特种医学 | 65篇 |
外科学 | 138篇 |
综合类 | 288篇 |
预防医学 | 42篇 |
眼科学 | 48篇 |
药学 | 36篇 |
1篇 | |
中国医学 | 5篇 |
肿瘤学 | 86篇 |
出版年
2022年 | 33篇 |
2021年 | 48篇 |
2020年 | 30篇 |
2019年 | 20篇 |
2018年 | 28篇 |
2017年 | 21篇 |
2016年 | 31篇 |
2015年 | 43篇 |
2014年 | 47篇 |
2013年 | 42篇 |
2012年 | 55篇 |
2011年 | 52篇 |
2010年 | 85篇 |
2009年 | 57篇 |
2008年 | 67篇 |
2007年 | 68篇 |
2006年 | 66篇 |
2005年 | 42篇 |
2004年 | 60篇 |
2003年 | 30篇 |
2002年 | 38篇 |
2001年 | 33篇 |
2000年 | 23篇 |
1999年 | 26篇 |
1998年 | 32篇 |
1997年 | 32篇 |
1996年 | 29篇 |
1995年 | 21篇 |
1994年 | 23篇 |
1993年 | 8篇 |
1992年 | 10篇 |
1991年 | 12篇 |
1990年 | 6篇 |
1989年 | 9篇 |
1988年 | 11篇 |
1987年 | 14篇 |
1986年 | 12篇 |
1985年 | 13篇 |
1984年 | 9篇 |
1983年 | 3篇 |
1982年 | 6篇 |
1981年 | 5篇 |
1980年 | 2篇 |
1979年 | 7篇 |
1978年 | 5篇 |
1977年 | 4篇 |
1976年 | 4篇 |
1974年 | 2篇 |
1972年 | 2篇 |
1953年 | 1篇 |
排序方式: 共有1331条查询结果,搜索用时 15 毫秒
111.
112.
The Indian Armed Forces Medical Services has been engaged in providing medical to the soldiers serving on Siachen Glacier for the last 25 years. This paper attempts to highlight the medical problems faced by troops on the world's highest battlefield as perceived by a medical officer located on the forward most medical echelon on Siachen Glacier. The medical problems on the glacier include high altitude pulmonary oedema, acute mountain sickness, frost bite chilblains, hypothermia, snow blindness, injury non enemy action due to avalanches, crevasses and fires, carbon monoxide poisoning and problems in disposal of nightsoil. A large number of problems are taken care of by following a well documented acclimatisation drill. However under such conditions providing medical support is a difficult task and requires innovations and improvisations entailing a high degree of mental mobility on the part of medical commanders and the Regimental Medical Officers located on the forward posts. 相似文献
113.
114.
115.
116.
Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting 总被引:1,自引:0,他引:1
Kai Chen Jin Xie Hengyi Xu Deepak Behera Mark H. Michalski Sandip Biswal Andrew Wang Xiaoyuan Chen 《Biomaterials》2009,30(36):6912-6919
A key challenge in developing nanoplatform-based molecular imaging is to achieve an optimal pharmacokinetic profile to allow sufficient targeting and to avoid rapid clearance by the reticuloendothelial system (RES). In the present study, iron oxide nanoparticles (IONPs) were coated with a PEGylated amphiphilic triblock copolymer, making them water soluble and function-extendable. These particles were then conjugated with a near-infrared fluorescent (NIRF) dye IRDye800 and cyclic Arginine-Glycine-Aspartic acid (RGD) containing peptide c(RGDyK) for integrin αvβ3 targeting. In vitro binding assays confirmed the integrin-specific association between the RGD-particle adducts and U87MG glioblastoma cells. Successful tumor homing in vivo was perceived in a subcutaneous U87MG glioblastoma xenograft model by both magnetic resonance imaging (MRI) and NIRF imaging. Ex vivo histopathological studies also revealed low particle accumulation in the liver, which was attributed to their compact hydrodynamic size and PEGylated coating. In conclusion, we have developed a novel RGD–IONP conjugate with excellent tumor integrin targeting efficiency and specificity as well as limited RES uptake for molecular MRI. 相似文献
117.
Guomiao Shen Digambar Behera Manpreet Bhalla Arthur Nadas Suman Laal 《Clinical and Vaccine Immunology : CVI》2009,16(1):49-54
Tuberculosis (TB) is a major cause of morbidity and mortality, especially in developing countries. Despite significant limitations, microscopy remains the cornerstone of the global TB control strategy. As the TB epidemic escalates, new diagnostic methods that are accurate and also economical and simple to manufacture and deploy are urgently needed. Although several promising antigens have been identified and evaluated in recent years, the reproducible production of high-quality recombinant mycobacterial proteins with minimal batch-to-batch variation is difficult, laborious, and expensive. To determine the feasibility of devising a synthetic peptide-based diagnostic test for TB, we have delineated the immunodominant epitopes of three candidate antigens, Ag85B, BfrB, and TrxC, that were previously identified to be immunogenic in TB patients. The results demonstrate that combinations of carefully selected synthetic peptides derived from highly immunogenic proteins can be the basis for devising an immunodiagnostic test for TB. 相似文献
118.
119.
Intralesional immunotherapy with killed Mycobacterium w vaccine for the treatment of ano-genital warts: an open label pilot study 总被引:1,自引:0,他引:1
S Gupta AK Malhotra KK Verma VK Sharma 《Journal of the European Academy of Dermatology and Venereology》2008,22(9):1089-1093
Background Intralesional immunotherapy with skin test antigens and vaccines has been found to be effective in the management of genital and extragenital warts.
Objective To evaluate the efficacy and safety of intralesional Mycobacterium w (M w ) vaccine monotherapy for the treatment of ano-genital warts.
Patients and methods Ten patients clinically diagnosed to have external ano-genital warts, including three with giant ano-genital warts (Buschke Löwenstein tumour), were included in this open-label pilot study. Two patients were human immunodeficiency virus seropositive, and one was on iatrogenic immunosuppression for renal transplantation. M w vaccine (0.1 mL) was initially injected intradermally in the deltoid region on both the sides, followed 2 weeks later by intradermal intralesional injection into the genital warts. Intralesional injections were repeated weekly until either complete clearance or a maximum of 10 injections was achieved.
Results One patient was lost to follow-up after the first intralesional injection. In 8 out of remaining 9 patients (88.9%), the genital warts cleared completely. In one patient with giant perianal wart, the lesion was reduced to less than 5% of its volume after 10 intralesional injections, which was later electrosurgically excised. The treatment was well tolerated by the majority of the patients. The adverse reactions were noted in four patients, which were reversible. No recurrence was seen after a mean follow-up of 5.1 months.
Conclusion Intralesional immunotherapy of ano-genital warts with M w vaccine seems to be a promising new approach, which needs to be evaluated in the randomized controlled trials. 相似文献
Objective To evaluate the efficacy and safety of intralesional Mycobacterium w (M w ) vaccine monotherapy for the treatment of ano-genital warts.
Patients and methods Ten patients clinically diagnosed to have external ano-genital warts, including three with giant ano-genital warts (Buschke Löwenstein tumour), were included in this open-label pilot study. Two patients were human immunodeficiency virus seropositive, and one was on iatrogenic immunosuppression for renal transplantation. M w vaccine (0.1 mL) was initially injected intradermally in the deltoid region on both the sides, followed 2 weeks later by intradermal intralesional injection into the genital warts. Intralesional injections were repeated weekly until either complete clearance or a maximum of 10 injections was achieved.
Results One patient was lost to follow-up after the first intralesional injection. In 8 out of remaining 9 patients (88.9%), the genital warts cleared completely. In one patient with giant perianal wart, the lesion was reduced to less than 5% of its volume after 10 intralesional injections, which was later electrosurgically excised. The treatment was well tolerated by the majority of the patients. The adverse reactions were noted in four patients, which were reversible. No recurrence was seen after a mean follow-up of 5.1 months.
Conclusion Intralesional immunotherapy of ano-genital warts with M w vaccine seems to be a promising new approach, which needs to be evaluated in the randomized controlled trials. 相似文献
120.